These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31165271)

  • 1. Management of Fulminant Hepatitis B.
    Ichai P; Samuel D
    Curr Infect Dis Rep; 2019 Jun; 21(7):25. PubMed ID: 31165271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing etiologies and outcomes of acute liver failure: A perspective from Japan.
    Oketani M; Ido A; Tsubouchi H
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():65-71. PubMed ID: 21199516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfavorable prognosis of patients with acute liver injury due to drug-induced liver injury and acute exacerbation of hepatitis B virus infection.
    Kakisaka K; Suzuki Y; Jinnouchi Y; Kanazawa J; Sasaki T; Yonezawa T; Yoshida Y; Kuroda H; Takikawa Y
    Hepatol Res; 2019 Nov; 49(11):1286-1293. PubMed ID: 31251432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New era of liver transplantation for hepatitis B: a 17-year single-center experience.
    Anselmo DM; Ghobrial RM; Jung LC; Weaver M; Cao C; Saab S; Kunder G; Chen PW; Farmer DG; Yersiz H; Baquerizo A; Geevarghese S; Han SH; Goldstein L; Holt CD; Gornbein JA; Busuttil RW
    Ann Surg; 2002 May; 235(5):611-9; discussion 619-20. PubMed ID: 11981206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.
    Sawyer RG; McGory RW; Gaffey MJ; McCullough CC; Shephard BL; Houlgrave CW; Ryan TS; Kuhns M; McNamara A; Caldwell SH; Abdulkareem A; Pruett TL
    Ann Surg; 1998 Jun; 227(6):841-50. PubMed ID: 9637547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
    Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.
    Novelli G; Rossi M; Pretagostini R; Poli L; Novelli L; Berloco P; Ferretti G; Iappelli M; Cortesini R
    Liver; 2002; 22 Suppl 2():43-7. PubMed ID: 12220303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization.
    al-Hemsi B; McGory RW; Shepard B; Ishitani MB; Stevenson WC; McCullough C; Pruett TL
    Clin Transplant; 1996 Dec; 10(6 Pt 2):668-75. PubMed ID: 8996763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009.
    Oketani M; Ido A; Nakayama N; Takikawa Y; Naiki T; Yamagishi Y; Ichida T; Mochida S; Onishi S; Tsubouchi H;
    Hepatol Res; 2013 Feb; 43(2):97-105. PubMed ID: 23409848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis.
    Sterneck M; Günther S; Gerlach J; Naoumov NV; Santantonio T; Fischer L; Rogiers X; Greten H; Williams R; Will H
    J Hepatol; 1997 Apr; 26(4):754-64. PubMed ID: 9126786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation.
    Ku W; Wang U; Nguyen MH
    Expert Opin Biol Ther; 2015 May; 15(5):665-77. PubMed ID: 25865452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.
    Katz LH; Tur-Kaspa R; Guy DG; Paul M
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006005. PubMed ID: 20614442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey.
    Sato S; Suzuki K; Takikawa Y; Endo R; Omata M;
    Hepatol Res; 2004 Nov; 30(3):155-161. PubMed ID: 15588781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for hepatitis B-induced liver disease: long-term outcome and effectiveness of antiviral therapy for prevention of recurrent hepatitis B infection.
    Perrakis A; Förtsch T; Del Medico A; Croner RS; Vassos N; Yedibela S; Lohmüller C; Zopf S; Hohenberger W; Müller V
    Transplant Proc; 2013 Jun; 45(5):1953-6. PubMed ID: 23769081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-control study for the identification of virological factors associated with fulminant hepatitis B.
    Kusakabe A; Tanaka Y; Mochida S; Nakayama N; Inoue K; Sata M; Isoda N; Kang JH; Sumino Y; Yatsuhashi H; Takikawa Y; Kaneko S; Yamada G; Karino Y; Tanaka E; Kato J; Sakaida I; Izumi N; Sugauchi F; Nojiri S; Joh T; Miyakawa Y; Mizokami M
    Hepatol Res; 2009 Jul; 39(7):648-56. PubMed ID: 19456899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
    Gane EJ; Patterson S; Strasser SI; McCaughan GW; Angus PW
    Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus.
    Marsman WA; Wiesner RH; Batts KP; Poterucha JJ; Porayko MK; Niesters HG; Zondervan PE; Krom RA
    Hepatology; 1997 Feb; 25(2):434-8. PubMed ID: 9021960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.